| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $225M | — | $213M | — | 5.3% |
| Op. Income | $40M | — | $20M | — | 98.9% |
| Gross Margin | 51.3% | — | 43.8% | — | 7.5pp |
| Net Margin | 13.5% | — | 7.3% | — | 6.2pp |
| EPS (Diluted) | $3.75 | — | $1.91 | — | 96.3% |
| Free Cash Flow | $30M | — | $25M | — | 20.6% |
| Item | Amount |
|---|---|
| REVENUE | $225M |
| Cost of Revenue | $109M |
| GROSS PROFIT | $115M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $55M |
| SG&A Expenses | $55M |
| Other Expenses | $21M |
| Operating Expenses | $76M |
| Cost & Expenses | $185M |
| OPERATING INCOME | $40M |
| Interest Income | $211M |
| Interest Expense | $107M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $40M |
| Income Tax Expense | $9M |
| Net Income from Continuing Ops | $30M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $30M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $30M |
| D&A | $5M |
| EBIT | $40M |
| EBITDA | $44M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $225M |
| Cost of Revenue | $109M |
| GROSS PROFIT | $115M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $55M |
| SG&A Expenses | $55M |
| Other Expenses | $21M |
| Operating Expenses | $76M |
| Cost & Expenses | $185M |
| OPERATING INCOME | $40M |
| Interest Income | $211M |
| Interest Expense | $107M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $40M |
| Income Tax Expense | $9M |
| Net Income from Continuing Ops | $30M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $30M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $30M |
| D&A | $5M |
| EBIT | $40M |
| EBITDA | $44M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $30M |
| Depreciation & Amortization | $5M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | -$1M |
| Other Non-Cash Items | -$5M |
| Change in Working Capital | -$458.0K |
| OPERATING CASH FLOW | $30M |
| Capital Expenditure | -$581.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $30M |
| Other Investing Activities | -$235M |
| NET CASH FROM INVESTING | -$206M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $281M |
| NET CASH FROM FINANCING | $283M |
| FREE CASH FLOW | $30M |
| Net Change in Cash | $107M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $28M |
| Short-Term Investments | $128M |
| Net Receivables | $12M |
| Inventory | $0 |
| Other Current Assets | -$12M |
| TOTAL CURRENT ASSETS | $156M |
| PP&E (Net) | $83M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $3.9B |
| Tax Assets | $14M |
| Other Non-Current Assets | -$4.0B |
| TOTAL NON-CURRENT ASSETS | $83M |
| TOTAL ASSETS | $4.4B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $3.7B |
| TOTAL CURRENT LIABILITIES | $3.7B |
| Long-Term Debt | $265M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $7M |
| Other Non-Current Liabilities | $3.7B |
| TOTAL NON-CURRENT LIABILITIES | $4.0B |
| TOTAL LIABILITIES | $4.0B |
| Common Stock | $82.0K |
| Additional Paid-In Capital | $126M |
| Retained Earnings | $251M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$9M |
| Other Equity | -$1M |
| TOTAL STOCKHOLDERS' EQUITY | $369M |
| Minority Interest | $0 |
| TOTAL EQUITY | $369M |
| TOTAL LIABILITIES & EQUITY | $4.4B |
| Total Debt | $265M |
| Net Debt | $237M |
